Table 2.
Donor and graft characteristics stratified by recipient survival
| Variable | <1 year survival | 1–10 year survival | >10 year survival | p-value |
|---|---|---|---|---|
| (n=964) | (n=2,843) | (n=1,364) | ||
| Male sex | 559 (58.0%) | 1,713 (60.3%) | 848 (62.2%) | 0.126 |
| Age (years, median, IQR) | 31 (21–46) | 31 (21–47) | 29 (20–45) | 0.046 |
| BMI (kg/m2, median, IQR) | 24.5 (21.9–27.6) | 24.7 (22.0–27.8) | 24.6 (21.9–27.5) | 0.453 |
| Race/ethnicity | <0.001 | |||
| White | 556 (57.7%) | 1,825 (64.2%) | 881 (64.6%) | |
| Black | 222 (23.0%) | 496 (17.4%) | 225 (16.5%) | |
| Hispanic | 157 (16.3%) | 416 (14.6%) | 199 (14.6%) | |
| Other | 29 (3.0%) | 106 (3.7%) | 59 (4.3%) | |
| Cigarette use | 167 (17.5%) | 429 (15.2%) | 176 (13.0%) | 0.010 |
| Cocaine use | 112 (11.7%) | 323 (11.5%) | 137 (10.2%) | 0.396 |
| Diabetes | 72 (7.5%) | 158 (5.6%) | 59 (4.3%) | 0.005 |
| Hypertension | 229 (23.9%) | 571 (20.2%) | 253 (18.6%) | 0.007 |
| Cancer | 13 (1.4%) | 60 (2.1%) | 25 (1.8%) | 0.323 |
| Pulmonary infection | 314 (32.6%) | 861 (30.3%) | 395 (29.0%) | 0.173 |
| Creatinine (mg/dL, median, IQR) | 1.0 (0.8–1.3) | 1.0 (0.8–1.3) | 1.0 (0.8–1.3) | 0.518 |
| Total bilirubin (mg/dL, median, IQR) | 0.8 (0.5–1.3) | 0.8 (0.5–1.2) | 0.7 (0.5–1.2) | 0.022 |
| P/F ratio | 456 (387–511) | 445 (376–506) | 447 (383–502) | 0.048 |
| Cause of death | 0.615 | |||
| Anoxia | 90 (9.3%) | 281 (9.9%) | 145 (10.6%) | |
| Cerebrovascular/stroke | 383 (39.7%) | 1,048 (36.9%) | 475 (34.8%) | |
| Head trauma | 462 (47.9%) | 1,430 (50.3%) | 700 (51.3%) | |
| CNS tumor | 8 (0.8%) | 22 (0.8%) | 12 (0.9%) | |
| Other | 21 (2.2%) | 62 (2.2%) | 32 (2.3%) | |
| Graft ischemic time (hours, median, IQR) | 4.9 (4.0–6.1) | 4.8 (3.8–6.0) | 5.1 (4.2–6.2) | <0.001 |
IQR, interquartile range; BMI, body mass index; CNS, central nervous system